Suzhou Highfine Biotech Co., Ltd. Stock: price and insider trades · China
昊帆生物
No insider purchase over the last 90 days. The latest, by 吕敏杰, was filed 18 Jul 2024.
Suzhou Highfine Biotech Co., Ltd.: what insiders have been doing
Suzhou Highfine Biotech Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Nothing new has been filed by managers of Suzhou Highfine Biotech Co., Ltd. in twelve months, the latest record being from 18 July 2024.
Looking back to 2024, when coverage begins, insiders filed 10 purchases and no sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +37.5%Entry CN¥40.56 · Close at T+365 CN¥55.78
- +34.3%Entry CN¥40.76 · Close at T+365 CN¥54.74
- +34.3%Entry CN¥40.76 · Close at T+365 CN¥54.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 15,700 shares63.5% of flowA股XSHESZSE:173000007860432400Canonical exit: 16 Oct 2024 (T+90)
- 17,200 shares67.7% of flowA股XSHESZSE:173000007855017470Canonical exit: 15 Oct 2024 (T+90)
- 33,000 shares76.9% of flowA股XSHESZSE:173000007855017500Canonical exit: 15 Oct 2024 (T+90)
- 32,400 shares23.1% of flowA股XSHESZSE:173000007850847460Canonical exit: 14 Oct 2024 (T+90)
- 1,000 shares2.3% of flowA股XSHESZSE:173000007834077100Canonical exit: 8 Oct 2024 (T+90)
- 9,000 shares36.5% of flowA股XSHESZSE:173000007830646750Canonical exit: 7 Oct 2024 (T+90)
- 13,000 shares9.2% of flowA股XSHESZSE:173000007830646720Canonical exit: 7 Oct 2024 (T+90)
- 97,100 shares67.7% of flowA股XSHESZSE:173000007827720500Canonical exit: 6 Oct 2024 (T+90)
- 9,000 shares20.7% of flowA股XSHESZSE:173000007819032200Canonical exit: 2 Oct 2024 (T+90)
- 8,300 shares32.3% of flowA股XSHESZSE:173000007819032220Canonical exit: 2 Oct 2024 (T+90)
10 of 10 declarations
About Suzhou Highfine Biotech Co., Ltd.
昊帆生物 is a company focused on the health and pharmaceutical sector, specializing in the development of biopharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
